Close

Alexion Pharma (ALXN) to Resume Trading at 5 PM ET

Go back to Alexion Pharma (ALXN) to Resume Trading at 5 PM ET

Alexion Pharma (ALXN) Offers Update on 10-Q Submission; Says Investigating Soliris Sales Practices

November 9, 2016 4:32 PM EST

Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) announced that it has filed with the U.S. Securities and Exchange Commission (SEC) a Form 12b-25 Notification of Late Filing with regard to its Quarterly Report on Form 10-Q for the quarter ended September 30, 2016.

The Audit and Finance Committee of the Board of Directors is... More

Alexion Pharma (ALXN) Files to Delay Form 10-Q; Notes Investigation of Sales Practices

November 9, 2016 4:27 PM EST

Alexion Pharma (Nasdaq: ALXN) filed to delay Form 10-Q. The company noted the following:

The Audit and Finance Committee of the Board of Directors of Alexion... More

Alexion Pharma (ALXN) Halted, News Pending

November 9, 2016 4:19 PM EST

Alexion Pharma (NASDAQ: ALXN) Halted, News Pending

... More